AR and breast carcinoma: To evaluate whether AR agonism or antagonism affects the expression and/or stability of AR-V7 in breast cancer, RNA and protein were isolated from MDA-MB-453 cells treated for 24 h with DHT, bicalutamide or enzalutamide.